Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

741 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Injectable hydrogels for personalized cancer immunotherapies.
Mohaghegh N, Ahari A, Zehtabi F, Buttles C, Davani S, Hoang H, Tseng K, Zamanian B, Khosravi S, Daniali A, Kouchehbaghi NH, Thomas I, Serati Nouri H, Khorsandi D, Abbasgholizadeh R, Akbari M, Patil R, Kang H, Jucaud V, Khademhosseini A, Hassani Najafabadi A. Mohaghegh N, et al. Among authors: tseng k. Acta Biomater. 2023 Dec;172:67-91. doi: 10.1016/j.actbio.2023.10.002. Epub 2023 Oct 6. Acta Biomater. 2023. PMID: 37806376 Review.
Sodium Phytate-Incorporated Gelatin-Silicate Nanoplatelet Composites for Enhanced Cohesion and Hemostatic Function of Shear-Thinning Biomaterials.
Zehtabi F, Montazerian H, Haghniaz R, Tseng K, Mohaghegh N, Mandal K, Zamanian B, Dokmeci MR, Akbari M, Hassani Najafabadi A, Kim HJ, Khademhosseini A. Zehtabi F, et al. Among authors: tseng k. Macromol Biosci. 2023 Jan;23(1):e2200333. doi: 10.1002/mabi.202200333. Epub 2022 Oct 26. Macromol Biosci. 2023. PMID: 36287084 Free PMC article.
Injectable Shear-Thinning Hydrogels with Sclerosing and Matrix Metalloproteinase Modulatory Properties for the Treatment of Vascular Malformations.
Zehtabi F, Gangrade A, Tseng K, Haghniaz R, Abasgholizadeh R, Montazerian H, Khorsandi D, Bahari J, Ahari A, Mohaghegh N, Kouchehbaghi NH, Mandal K, Mecwan M, Rashad A, de Barros NR, Byun Y, Ermis M, Kim HJ, Khademhosseini A. Zehtabi F, et al. Among authors: tseng k. Adv Funct Mater. 2023 Dec 15;33(51):2305880. doi: 10.1002/adfm.202305880. Epub 2023 Sep 8. Adv Funct Mater. 2023. PMID: 38558868
Nanoparticles-based technologies for cholera detection and therapy.
Ho N, Tang K, Ngo V, Livits I, Morrel A, Noor B, Tseng K, Chung EJ. Ho N, et al. Among authors: tseng k. SLAS Technol. 2023 Dec;28(6):384-392. doi: 10.1016/j.slast.2023.10.006. Epub 2023 Nov 3. SLAS Technol. 2023. PMID: 37925157 Free article. Review.
Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan.
Yang CC, Huang CF, Chang TS, Lo CC, Hung CH, Huang CW, Chong LW, Cheng PN, Yeh ML, Peng CY, Cheng CY, Huang JF, Bair MJ, Lin CL, Yang CC, Wang SJ, Hsieh TY, Lee TH, Lee PL, Wu WC, Lin CL, Su WW, Yang SS, Wang CC, Hu JT, Mo LR, Chen CT, Huang YH, Chang CC, Huang CS, Chen GY, Kao CN, Tai CM, Liu CJ, Lee MH, Kuo HT, Tsai PC, Dai CY, Kao JH, Lin HC, Chuang WL, Tseng KC, Chen CY, Yu ML. Yang CC, et al. Among authors: tseng kc. Infect Dis Ther. 2024 Apr 28. doi: 10.1007/s40121-024-00968-5. Online ahead of print. Infect Dis Ther. 2024. PMID: 38679663
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
Tsai PC, Huang CF, Yeh ML, Hsieh MH, Kuo HT, Hung CH, Tseng KC, Lai HC, Peng CY, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Kao JH, Liu CJ, Liu CH, Yan SL, Lin CY, Su WW, Chu CH, Chen CJ, Tung SY, Tai CM, Lin CW, Lo CC, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Chen CY, Huang JF, Dai CY, Wan-Long WL, Bair MJ, Yu ML; T-COACH Study Group. Tsai PC, et al. Among authors: tseng kc. Clin Mol Hepatol. 2024 Apr 19. doi: 10.3350/cmh.2024.0038. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 38637957 Free article.
741 results